Ruifeng F. Zhang

Nanjing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Real-world effectiveness and safety of adebrelimab as first-line treatment in patients with extensive-stage small cell lung cancer.

Real-world effectiveness and safety of adebrelimab as first-line treatment in patients with extensive-stage small cell lung cancer.

Journal: Translational lung cancer research

Published: November 06, 2025

Methyltransferase-Like 3-Driven N6-Methyladenosine Modification of Recombination Signal Binding Protein for Immunoglobulin Kappa J Region Promotes Vascular Remodeling in Pulmonary Hypertension.

Methyltransferase-Like 3-Driven N6-Methyladenosine Modification of Recombination Signal Binding Protein for Immunoglobulin Kappa J Region Promotes Vascular Remodeling in Pulmonary Hypertension.

Journal: The American journal of pathology

Published: May 03, 2024

Impact of different sequential triple oral combination therapies based selexipag on outcomes in pulmonary arterial hypertension.

Impact of different sequential triple oral combination therapies based selexipag on outcomes in pulmonary arterial hypertension.

Journal: Clinical cardiology

Published: December 27, 2023

Differential expression and analysis of extrachromosomal circular DNAs as serum biomarkers in pulmonary arterial hypertension.

Differential expression and analysis of extrachromosomal circular DNAs as serum biomarkers in pulmonary arterial hypertension.

Journal: Respiratory research

Published: October 29, 2023

Safety and efficacy of inhalable ambroxol hydrochloride aerosol for adult patients with respiratory diseases: an open-label, single-arm, multicentre study.

Safety and efficacy of inhalable ambroxol hydrochloride aerosol for adult patients with respiratory diseases: an open-label, single-arm, multicentre study.

Journal: BMJ open respiratory research

Published: September 27, 2023

Correction to: Prediction and prognosis of adverse maternal and foetal/neonatal outcomes in pulmonary hypertension: an observational study and nomogram construction.

Correction to: Prediction and prognosis of adverse maternal and foetal/neonatal outcomes in pulmonary hypertension: an observational study and nomogram construction.

Journal: Respiratory research

Published: January 07, 2023

Prediction and prognosis of adverse maternal and foetal/neonatal outcomes in pulmonary hypertension: an observational study and nomogram construction.

Prediction and prognosis of adverse maternal and foetal/neonatal outcomes in pulmonary hypertension: an observational study and nomogram construction.

Journal: Respiratory research

Published: October 12, 2022

Alleviating experimental pulmonary hypertension via co-delivering FoxO1 stimulus and apoptosis activator to hyperproliferating pulmonary arteries.

Alleviating experimental pulmonary hypertension via co-delivering FoxO1 stimulus and apoptosis activator to hyperproliferating pulmonary arteries.

Journal: Acta pharmaceutica Sinica. B

Published: September 02, 2022

A rare compound heterozygous EIF2AK4 mutation in pulmonary veno-occlusive disease.

A rare compound heterozygous EIF2AK4 mutation in pulmonary veno-occlusive disease.

Journal: BMC pulmonary medicine

Published: May 13, 2022

Phenotype and genetic mutation analysis of an inherited protein C deficiency pedigree

Phenotype and genetic mutation analysis of an inherited protein C deficiency pedigree

Journal: Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases

Published: December 16, 2021

Good response to pulmonary arterial hypertension-targeted therapy in 2 pulmonary veno-occlusive disease patients: A case report.

Good response to pulmonary arterial hypertension-targeted therapy in 2 pulmonary veno-occlusive disease patients: A case report.

Journal: Medicine

Published: July 02, 2021

Showing 1-11 of 11

Last Updated: 09/26/2026